Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

France 24

Experimental pancreatic cancer pill helps improve survival in late-stage study

Experimental pancreatic cancer pill helps improve survival in late-stage study
ShareXFacebook

Revolution Medicines' experimental oral drug ⁠helped patients ​with pancreatic cancer live longer and showed an improvement in survival without worsening ​of the disease in a keenly anticipated late-stage trial. Patients who received the once-daily pill, daraxonrasib, showed a median overall survival of 13.2 months compared with 6.7 months ​for ‌those who were given intravenous cytotoxic chemother

F

Source

France 24

Read full article at France 24

Opens original article in a new tab

Advertisement

Related World Stories

Advertisement